TOX is a critical regulator of tumour-specific T cell differentiation

被引:726
|
作者
Scott, Andrew C. [1 ,2 ]
Dundar, Friederike [3 ,4 ]
Zumbo, Paul [3 ,4 ]
Chandran, Smita S. [5 ,6 ]
Klebanoff, Christopher A. [5 ,6 ,7 ,8 ]
Shakiba, Mojdeh [1 ,3 ]
Trivedi, Prerak [1 ]
Menocal, Laura [1 ,2 ]
Appleby, Heather [1 ]
Camara, Steven [1 ]
Zamarin, Dmitriy [5 ,7 ]
Walther, Tyler [7 ]
Snyder, Alexandra [7 ]
Femia, Matthew R. [5 ,6 ]
Comen, Elizabeth A. [7 ,8 ]
Wen, Hannah Y. [9 ]
Hellmann, Matthew D. [5 ,7 ,8 ]
Anandasabapathy, Niroshana [2 ,10 ]
Liu, Yong [10 ]
Altorki, Nasser K. [11 ]
Lauer, Peter [12 ]
Levy, Olivier [1 ]
Glickman, Michael S. [1 ,2 ]
Kaye, Jonathan [13 ]
Betel, Doron [4 ,14 ,15 ]
Philip, Mary [1 ,16 ]
Schietinger, Andrea [1 ,2 ,5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA
[3] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA
[4] Weill Cornell Med, Appl Bioinformat Core, New York, NY USA
[5] Parker Inst Canc Immunotherapy, New York, NY 10017 USA
[6] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA
[7] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[8] Weill Cornell Med Coll, New York, NY USA
[9] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA
[10] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA
[11] New York Presbyterian Hosp, Dept Cardiothorac Surg, Weill Cornell Med, New York, NY USA
[12] Aduro Biotech Inc, Berkeley, CA USA
[13] Cedars Sinai Med Ctr, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA 90048 USA
[14] Weill Cornell Med, Dept Med, Div Hematol & Med Oncol, New York, NY USA
[15] Weill Cornell Med, Inst Computat Biomed, New York, NY USA
[16] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol & Oncol, Nashville, TN USA
关键词
EXHAUSTION; PROMOTES; DYSFUNCTION; ANTIGEN; AUTOIMMUNITY; EXPRESSION; GENERATION; PROTEINS; EFFECTOR; PROGRAM;
D O I
10.1038/s41586-019-1324-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumour-specific CD8 T cell dysfunction is a differentiation state that is distinct from the functional effector or memory T cell states(1-6). Here we identify the nuclear factor TOX as a crucial regulator of the differentiation of tumour-specific T (TST) cells. We show that TOX is highly expressed in dysfunctional TST cells from tumours and in exhausted T cells during chronic viral infection. Expression of TOX is driven by chronic T cell receptor stimulation and NFAT activation. Ectopic expression of TOX in effector T cells in vitro induced a transcriptional program associated with T cell exhaustion. Conversely, deletion of Tox in TST cells in tumours abrogated the exhaustion program: Tox-deleted TST cells did not upregulate genes for inhibitory receptors (such as Pdcd1, Entpd1, Havcr2, Cd244 and Tigit), the chromatin of which remained largely inaccessible, and retained high expression of transcription factors such as TCF-1. Despite their normal, 'non-exhausted' immunophenotype, Tox-deleted TST cells remained dysfunctional, which suggests that the regulation of expression of inhibitory receptors is uncoupled from the loss of effector function. Notably, although Tox-deleted CD8 T cells differentiated normally to effector and memory states in response to acute infection, Tox-deleted TST cells failed to persist in tumours. We hypothesize that the TOX-induced exhaustion program serves to prevent the overstimulation of T cells and activation-induced cell death in settings of chronic antigen stimulation such as cancer.
引用
收藏
页码:270 / +
页数:27
相关论文
共 50 条
  • [31] HUMAN TUMOUR-SPECIFIC ANTIGENS - FACT OR FANTASY
    TEE, DEH
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1967, 60 (11P1): : 1183 - &
  • [32] Polymer therapeutics and their combinations for tumour-specific delivery
    Duncan, R
    BRITISH JOURNAL OF CANCER, 2002, 86 : S12 - S12
  • [33] Orally Delivered Probiotic Bacteria As Tumour-Specific Gene/Cell Therapy Vectors
    Baban, C. B.
    Cronin, M. C.
    O'Hanlon, D. O. H.
    O'Sullivan, G. O. S.
    Tangney, M. T.
    HUMAN GENE THERAPY, 2011, 22 (10) : A80 - A80
  • [34] Disabling adenosine-mediated suppression of tumour-specific cytotoxic T lymphocyte function
    Basingab, F. S. H.
    Al-Yafei, Z.
    Koundouros, N.
    Morgan, D.
    IMMUNOLOGY, 2014, 143 : 60 - 60
  • [35] Autologous tumour-specific cytotoxic T-lymphocytes in osteosarcoma patients: a preclinical model
    Muraro, M.
    Signorino, E.
    Castiglia, S.
    Sangiolo, D.
    Mereuta, M.
    Saglio, F.
    Ferrero, I.
    Aglietta, M.
    Fagioli, F.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S381 - S382
  • [36] Recent research progress on tumour-specific responsive hydrogels
    Zhou, Xuan-Yi
    Wang, Chen-Kai
    Shen, Ze-Fan
    Wang, Yi-Fan
    Li, Yu-Hang
    Hu, Yu-Ning
    Zhang, Pu
    Zhang, Qi
    JOURNAL OF MATERIALS CHEMISTRY B, 2024, 12 (30) : 7246 - 7266
  • [37] Nodal interferon exposure drives tumour-specific tolerance
    Barranco, Caroline
    NATURE REVIEWS CANCER, 2022, 22 (07) : 377 - 377
  • [38] Tumour-specific hybrid nanoparticles in therapy of breast cancer
    Kilicay, E.
    Erdal, E.
    Elci, P.
    Hazer, B.
    Denkbas, E. B.
    JOURNAL OF MICROENCAPSULATION, 2024, 41 (01) : 45 - 65
  • [39] Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer
    J M Coulson
    J Stanley
    P J Woll
    British Journal of Cancer, 1999, 80 : 1935 - 1944
  • [40] Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines
    Guo, Feng
    Kan, Kejia
    Rueckert, Felix
    Rueckert, Wolfgang
    Li, Lin
    Eberhard, Johannes
    May, Tobias
    Sticht, Carsten
    Dirks, Wilhelm G.
    Reissfelder, Christoph
    Pallavi, Prama
    Keese, Michael
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)